Literature DB >> 33980544

Dopamine Transporter Is a Master Regulator of Dopaminergic Neural Network Connectivity.

Douglas R Miller1, Dylan T Guenther1, Andrew P Maurer1, Carissa A Hansen1, Andrew Zalesky2,3, Habibeh Khoshbouei4.   

Abstract

Dopaminergic neurons of the substantia nigra pars compacta (SNC) and ventral tegmental area (VTA) exhibit spontaneous firing activity. The dopaminergic neurons in these regions have been shown to exhibit differential sensitivity to neuronal loss and psychostimulants targeting dopamine transporter. However, it remains unclear whether these regional differences scale beyond individual neuronal activity to regional neuronal networks. Here, we used live-cell calcium imaging to show that network connectivity greatly differs between SNC and VTA regions with higher incidence of hub-like neurons in the VTA. Specifically, the frequency of hub-like neurons was significantly lower in SNC than in the adjacent VTA, consistent with the interpretation of a lower network resilience to SNC neuronal loss. We tested this hypothesis, in DAT-cre/loxP-GCaMP6f mice of either sex, when activity of an individual dopaminergic neuron is suppressed, through whole-cell patch clamp electrophysiology, in either SNC or VTA networks. Neuronal loss in the SNC increased network clustering, whereas the larger number of hub-neurons in the VTA overcompensated by decreasing network clustering in the VTA. We further show that network properties are regulatable via a dopamine transporter but not a D2 receptor dependent mechanism. Our results demonstrate novel regulatory mechanisms of functional network topology in dopaminergic brain regions.SIGNIFICANCE STATEMENT In this work, we begin to untangle the differences in complex network properties between the substantia nigra pars compacta (SNC) and VTA, that may underlie differential sensitivity between regions. The methods and analysis employed provide a springboard for investigations of network topology in multiple deep brain structures and disorders.
Copyright © 2021 the authors.

Entities:  

Keywords:  complex network analysis; dopamine; dopamine neurons; dopamine transporter; substantia nigra; ventral tegmental area

Mesh:

Substances:

Year:  2021        PMID: 33980544      PMCID: PMC8221606          DOI: 10.1523/JNEUROSCI.0223-21.2021

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  162 in total

Review 1.  Pathoanatomy of Parkinson's disease.

Authors:  H Braak; E Braak
Journal:  J Neurol       Date:  2000-04       Impact factor: 4.849

2.  Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat.

Authors:  D P Figlewicz; S B Evans; J Murphy; M Hoen; D G Baskin
Journal:  Brain Res       Date:  2003-02-21       Impact factor: 3.252

Review 3.  Somatodendritic dopamine release: recent mechanistic insights.

Authors:  Margaret E Rice; Jyoti C Patel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

4.  Methamphetamine decreases mouse striatal dopamine transporter activity: roles of hyperthermia and dopamine.

Authors:  V Sandoval; G R Hanson; A E Fleckenstein
Journal:  Eur J Pharmacol       Date:  2000-12-15       Impact factor: 4.432

5.  Dopamine neuronal transport kinetics and effects of amphetamine.

Authors:  S R Jones; J D Joseph; L S Barak; M G Caron; R M Wightman
Journal:  J Neurochem       Date:  1999-12       Impact factor: 5.372

6.  Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport.

Authors:  Jacob U Fog; Habibeh Khoshbouei; Marion Holy; William A Owens; Christian Bjerggaard Vaegter; Namita Sen; Yelyzaveta Nikandrova; Erica Bowton; Douglas G McMahon; Roger J Colbran; Lynette C Daws; Harald H Sitte; Jonathan A Javitch; Aurelio Galli; Ulrik Gether
Journal:  Neuron       Date:  2006-08-17       Impact factor: 17.173

7.  Functional connectivity and brain networks in schizophrenia.

Authors:  Mary-Ellen Lynall; Danielle S Bassett; Robert Kerwin; Peter J McKenna; Manfred Kitzbichler; Ulrich Muller; Ed Bullmore
Journal:  J Neurosci       Date:  2010-07-14       Impact factor: 6.167

8.  Intact-Brain Analyses Reveal Distinct Information Carried by SNc Dopamine Subcircuits.

Authors:  Talia N Lerner; Carrie Shilyansky; Thomas J Davidson; Kathryn E Evans; Kevin T Beier; Kelly A Zalocusky; Ailey K Crow; Robert C Malenka; Liqun Luo; Raju Tomer; Karl Deisseroth
Journal:  Cell       Date:  2015-07-30       Impact factor: 41.582

9.  Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model.

Authors:  Stephanie Janezic; Sarah Threlfell; Paul D Dodson; Megan J Dowie; Tonya N Taylor; Dawid Potgieter; Laura Parkkinen; Steven L Senior; Sabina Anwar; Brent Ryan; Thierry Deltheil; Polina Kosillo; Milena Cioroch; Katharina Wagner; Olaf Ansorge; David M Bannerman; J Paul Bolam; Peter J Magill; Stephanie J Cragg; Richard Wade-Martins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

10.  Functional Connectivity of Chronic Cocaine Use Reveals Progressive Neuroadaptations in Neocortical, Striatal, and Limbic Networks.

Authors:  Caitlin A Orsini; Luis M Colon-Perez; Sara C Heshmati; Barry Setlow; Marcelo Febo
Journal:  eNeuro       Date:  2018-07-24
View more
  6 in total

Review 1.  Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity.

Authors:  Douglas R Miller; Mengfei Bu; Adithya Gopinath; Luis R Martinez; Habibeh Khoshbouei
Journal:  J Pharmacol Exp Ther       Date:  2021-09-17       Impact factor: 4.402

2.  Specific dopaminergic genetic variants influence impulsivity, cognitive deficit, and disease severity of Indian ADHD probands.

Authors:  Subhamita Maitra; Mahasweta Chatterjee; Anirban Roychowdhury; Chinmay Kumar Panda; Swagata Sinha; Kanchan Mukhopadhyay
Journal:  Mol Biol Rep       Date:  2022-05-13       Impact factor: 2.742

3.  α-Synuclein-induced dysregulation of neuronal activity contributes to murine dopamine neuron vulnerability.

Authors:  Abeer Dagra; Douglas R Miller; Min Lin; Adithya Gopinath; Fatemeh Shaerzadeh; Sharonda Harris; Zachary A Sorrentino; Jonatan Fullerton Støier; Sophia Velasco; Janelle Azar; Adetola R Alonge; Joseph J Lebowitz; Brittany Ulm; Mengfei Bu; Carissa A Hansen; Nikhil Urs; Benoit I Giasson; Habibeh Khoshbouei
Journal:  NPJ Parkinsons Dis       Date:  2021-08-18

4.  Early Life Social Stress Causes Sex- and Region-Dependent Dopaminergic Changes that Are Prevented by Minocycline.

Authors:  Clarissa Catale; Luisa Lo Iacono; Alessandro Martini; Constantin Heil; Ezia Guatteo; Nicola Biagio Mercuri; Maria Teresa Viscomi; Daniela Palacios; Valeria Carola
Journal:  Mol Neurobiol       Date:  2022-04-18       Impact factor: 5.682

5.  The dopamine transporter gene SLC6A3: multidisease risks.

Authors:  Maarten E A Reith; Sandhya Kortagere; Corinde E Wiers; Hui Sun; Manju A Kurian; Aurelio Galli; Nora D Volkow; Zhicheng Lin
Journal:  Mol Psychiatry       Date:  2021-10-14       Impact factor: 13.437

6.  A Novel and Selective Dopamine Transporter Inhibitor, (S)-MK-26, Promotes Hippocampal Synaptic Plasticity and Restores Effort-Related Motivational Dysfunctions.

Authors:  Shima Kouhnavardi; Alev Ecevitoglu; Vladimir Dragačević; Fabrizio Sanna; Edgar Arias-Sandoval; Predrag Kalaba; Michael Kirchhofer; Jana Lubec; Marco Niello; Marion Holy; Martin Zehl; Matthias Pillwein; Judith Wackerlig; Rita Murau; Andrea Mohrmann; Kathryn R Beard; Harald H Sitte; Ernst Urban; Claudia Sagheddu; Marco Pistis; Roberto Plasenzotti; John D Salamone; Thierry Langer; Gert Lubec; Francisco J Monje
Journal:  Biomolecules       Date:  2022-06-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.